Immune modulatory effects of oncogenic KRAS in cancer
Immune modulatory effects of oncogenic KRAS in cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Oncogenic
KRAS
mutations are the most frequent mutations in human cancer, but most difficult to target. While sustained proliferation caused by oncogenic
KRAS
-downstream signalling is a main driver of carcinogenesis, there is increasing evidence that it also mediates autocrine effects and crosstalk with the tumour microenvironment (TME...
Alternative Titles
Full title
Immune modulatory effects of oncogenic KRAS in cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bab2055f90cc4a4aa21071e579d430b6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bab2055f90cc4a4aa21071e579d430b6
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-020-19288-6
